ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 135 filers reported holding ROYALTY PHARMA PLC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,558,329 | -16.4% | 404,987 | -5.8% | 0.00% | -20.0% |
| Q2 2023 | $13,820,448 | +99.5% | 429,874 | +145.4% | 0.01% | +66.7% |
| Q4 2022 | $6,928,459 | +10.9% | 175,138 | +16.3% | 0.00% | 0.0% |
| Q3 2022 | $6,245,000 | +7.1% | 150,643 | +10.4% | 0.00% | 0.0% |
| Q2 2022 | $5,832,000 | +4.4% | 136,489 | -4.6% | 0.00% | 0.0% |
| Q1 2022 | $5,584,000 | -12.4% | 143,058 | -9.1% | 0.00% | 0.0% |
| Q4 2021 | $6,371,000 | +3.1% | 157,427 | -6.4% | 0.00% | 0.0% |
| Q3 2021 | $6,179,000 | +19.7% | 168,260 | +34.2% | 0.00% | 0.0% |
| Q2 2021 | $5,162,000 | -0.3% | 125,379 | +1.6% | 0.00% | 0.0% |
| Q1 2021 | $5,178,000 | -28.1% | 123,436 | -12.1% | 0.00% | -40.0% |
| Q4 2020 | $7,205,000 | +25.7% | 140,391 | +7.3% | 0.01% | 0.0% |
| Q3 2020 | $5,730,000 | – | 130,831 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |